By Debdeep Gupta | 20 Mar, 2024
Aurobindo Pharma share up nearly 2% on USFDA approval for nasal spray
Aurobindo Pharma shares up nearly 2% on USFDA approval for nasal spray, The share touched a 52-week high of Rs 1,177 on January 30, 2024, and a 52-week low of Rs 466 on March 21, 2023.Aurobindo Pharma's share price rose nearly 2 percent in the early trade on March 20 after the company received US Food & Drug Administration (USFDA) approval for nasal spray.At 9.18 am, Aurobindo Pharma was quoting a...